Feedback / Questions
AZD8205 - AstraZeneca
"AZD8205https://www.adcreview.com/drugmap/azd8205-is-a-b7-h4-targeting-adc-being-developed-by-astrazeneca/"
(@OncoZine)
Sep 19, 2022
Review
•
VTCN1
https://twitter.com/OncoZine/status/1572079201859284993
Sep 19, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious